odiparcil
Asset
Promotes glycosaminoglycan clearance.
- Stage
- Phase 2
- Modality
- Not known
- Target
- Not known
- 1
- Indication
- 1
- Trial
- 1
- Developer
Indications
1Mucopolysaccharidosis type VI
Phase 2, inventivapharma.com, Oct 31, 2026
In the full profile
- Owner and partners1
- Trials1
Every asset’s record: target, stage, trials and the evidence behind it.